Navigation Links
High-quality DNA/RNA from Microorganisms in Environmental Samples
Date:10/15/2008

THOROLD, ON, Oct. 15 /PRNewswire/ - Norgen Biotek Corp., an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids and protein purification, today announced the launch of two new kits for the isolation of nucleic acids from environmental samples, the Soil DNA Isolation Kit and the Water RNA/DNA Purification Kit. These kits are ideal for environmental microbiological studies, and provide high quality, inhibitor-free DNA and/or RNA that can be used in various downstream applications such as PCR.

The Soil DNA Isolation Kit allows for the isolation of genomic DNA from various microorganisms found in all types of soil samples, including soil with high humic acid content such as compost and manure. The purified DNA is of the highest quality and is fully compatible with downstream PCR applications, as humic substances and other PCR inhibitors are removed during the extraction. Norgen's Water RNA/DNA Purification Kit is designed for the isolation of genomic DNA and total RNA from the microorganisms found in water. The organic-free extracted RNA and DNA are of the highest quality, concentrated and free from PCR inhibitors.

"Our new kits for the isolation of DNA and RNA from environmental microorganisms represent an exciting addition to our line of high quality products. We listened to our customers' feedback that they routinely encounter high levels of PCR inhibiton in nucleic acids isolated from environmental samples. I am very pleased that our scientists rose to the challenge and designed high quality kits that purify nucleic acids free of PCR inhibitors. We are confident that microbiologists will be satisfied with the quality and quantity of DNA isolated from soil and water samples with these kits and will get meaningful PCR amplification results. We have found that these kits out-perform the leading environmental kits on the market," said Dr. Haj-Ahmad, President & CEO of Norgen Biotek.

About Norgen Biotek Corp.

Norgen is a privately-held Canadian biotechnology company specializing in the development, manufacturing and marketing of sample preparation. We develop innovative best-in-class kits to purify DNA, RNA, microRNA and proteins from variety of sample using our proprietary technology. Norgen is open to various modality of business opportunity.


'/>"/>
SOURCE Norgen Biotek Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions
2. Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey
3. Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment
4. Environmental Tectonics Corporation Announces a Multiple Sale for Monoplace Hyperbaric Chambers
5. Environmental Tectonics Corporations Sterilization Systems Group Announces New Contracts
6. Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment
7. Carbon hoofprint: Cows supplemented with rbST reduce agricultures environmental impact
8. Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters
9. Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates
10. Environmental Tectonics Corporations BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers
11. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, will feature ... compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, ... . Napabucasin is an orally-administered ... targeting STAT3. i Cancer stem cells (CSCs) possess ...
(Date:1/18/2017)... ... January 18, 2017 , ... Executive search ... in its continued commitment to the advancement of the clinical trials segment. Hosted ... related to clinical trial planning and management. , As executive talent specialists ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... federally funded bio-focused Manufacturing Innovation Institutes (MII). U.S. Secretary of Commerce Penny Pritzker ... Biopharmaceuticals (NIIMBL), and the Department of Defense has announced the award of a ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... CHI SCOPE Summit for Clinical Ops Executives (Hyatt Regency Miami, January 24-26). DrugDev ... examine vital clinical research issues such as trial performance metrics, patient enrollment diversity, ...
Breaking Biology Technology:
(Date:1/3/2017)... 2017 Onitor, provider of digital health technology ... an innovative biometric data-driven program designed to aid weight ... the 2017 Consumer Electronics Show (CES) in ... U.S., the World Health Organization (WHO), have identified lifestyle ... who are overweight or obese. WHO also states that ...
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
(Date:12/16/2016)... The global wearable medical device market, in terms of value, is ... billion in 2016, at a CAGR of 18.0% during the forecast ... Growth ... devices, launch of a growing number of smartphone-based healthcare apps compatible ... and increasing focus on physical fitness. Furthermore, growing ...
Breaking Biology News(10 mins):